Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19.
作者信息
Razazi Keyvan, Arrestier Romain, Haudebourg Anne Fleur, Botterel Francoise, Mekontso Dessap Armand
机构信息
Service de Médecine Intensive Réanimation, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, DMU Médecine, 94010, Créteil, France.
Faculté de Santé de Créteil, IMRB, GRC CARMAS, UPEC (Université Paris Est Créteil), 94010, Créteil, France.
出版信息
Crit Care. 2021 Sep 26;25(1):348. doi: 10.1186/s13054-021-03767-3.
Abstract
摘要
相似文献
1
Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19.与新型冠状病毒肺炎（COVID-19）相关或不相关的病毒性急性呼吸窘迫综合征患者发生肺孢子菌肺炎的风险
Crit Care. 2021 Sep 26;25(1):348. doi: 10.1186/s13054-021-03767-3.
2
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19".新型冠状病毒肺炎合并耶氏肺孢子菌肺炎：一种被忽视的临床实体——对“与新型冠状病毒肺炎相关或不相关的病毒性急性呼吸窘迫综合征患者中肺孢子菌肺炎的风险”的回应
Crit Care. 2021 Dec 6;25(1):418. doi: 10.1186/s13054-021-03836-7.
3
Molecular epidemiology linking multihospital clusters of opportunistic Pneumocystis jirovecii pneumonia.将多医院机会性耶氏肺孢子菌肺炎聚集性病例相联系的分子流行病学研究
Clin Infect Dis. 2013 Oct;57(7):1058-9. doi: 10.1093/cid/cit413. Epub 2013 Jun 20.
4
Risk factors and multi-pathogen infections in kidney transplant recipients with omicron variant pneumonia: a retrospective analysis.奥密克戎变异株肺炎肾移植受者的危险因素及多病原体感染：回顾性分析。
BMC Infect Dis. 2024 Jun 4;24(1):559. doi: 10.1186/s12879-024-09444-4.
5
[Pneumonia due to Pneumocystis carinii in HIV-infected children].[人类免疫缺陷病毒感染儿童的卡氏肺孢子虫肺炎]
Gac Med Mex. 2004 Jan-Feb;140(1):59-69.
6
Early bacterial co-infection in ARDS related to COVID-19.与新型冠状病毒肺炎相关的急性呼吸窘迫综合征中的早期细菌合并感染
Intensive Care Med. 2020 Sep;46(9):1787-1789. doi: 10.1007/s00134-020-06165-5. Epub 2020 Jul 13.
7
A Case of COVID-19 and Coinfection.一例新型冠状病毒肺炎合并感染病例
Am J Respir Crit Care Med. 2020 Jul 1;202(1):136-138. doi: 10.1164/rccm.202003-0766LE.
8
Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.耶氏肺孢子菌肺炎的患病率（2010 - 2013年）：克罗地亚的首份报告。
Acta Microbiol Immunol Hung. 2014 Jun;61(2):181-8. doi: 10.1556/AMicr.61.2014.2.8.
9
Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran.COVID-19 流行地区的机会性真菌感染：来自伊朗的临床和诊断视角。
Mycopathologia. 2020 Aug;185(4):607-611. doi: 10.1007/s11046-020-00472-7. Epub 2020 Jul 31.
10
Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19.血清铁蛋白是新型冠状病毒肺炎中急性呼吸窘迫综合征的独立危险因素。
J Infect. 2020 Dec;81(6):979-997. doi: 10.1016/j.jinf.2020.09.006. Epub 2020 Sep 15.
引用本文的文献
1
Quantitative real time PCR for distinction between infection/colonization in hospitalized patients.定量实时 PCR 用于区分住院患者的感染/定植。
Front Cell Infect Microbiol. 2024 Sep 24;14:1426200. doi: 10.3389/fcimb.2024.1426200. eCollection 2024.
2
COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland.波兰重症监护病房患者中的新型冠状病毒肺炎相关肺曲霉病
J Fungi (Basel). 2023 Jun 13;9(6):666. doi: 10.3390/jof9060666.
3
pneumonia in COVID-19 patients: A comprehensive review.新型冠状病毒肺炎患者的肺炎：一项全面综述。
Heliyon. 2023 Feb;9(2):e13618. doi: 10.1016/j.heliyon.2023.e13618. Epub 2023 Feb 10.
4
Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use.研究发现，新冠急性呼吸窘迫综合征（COVID ARDS）与卡氏肺孢子虫肺炎（PCP）可能发生或确诊的低风险相关：使用地塞米松后依然如此。
Crit Care. 2022 Feb 10;26(1):41. doi: 10.1186/s13054-022-03886-5.
5
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19".新型冠状病毒肺炎合并耶氏肺孢子菌肺炎：一种被忽视的临床实体——对“与新型冠状病毒肺炎相关或不相关的病毒性急性呼吸窘迫综合征患者中肺孢子菌肺炎的风险”的回应
Crit Care. 2021 Dec 6;25(1):418. doi: 10.1186/s13054-021-03836-7.
Zotero 插件